The National Health Service (NHS) in England has ceased prescribing puberty blockers for children and young people with gender dysphoria. The decision has sparked criticism from LGBTQ groups.
From now puberty blockers will only be available in clinical trials and some private clinics, affecting fewer than 100 current NHS patients.